Chlorhexidine (di)gluconate locking device for central line infection prevention in intensive care unit patients: A multi-unit, pilot randomized controlled trial.
Purpose: Intensive care unit (ICU) patients are at risk for central line-associated bloodstream infection (CLABSI) with significant attributable mortality and increased hospital length of stay, readmissions, and costs. Chlorhexidine (di)gluconate (CHG) is used as a disinfectant for central line inse...
| Published in: | Vascular Access Vol. 16; no. 1; pp. 6 - 20 |
|---|---|
| Main Authors: | , , , |
| Format: | research tables/charts randomized controlled trial Journal Article |
| Published: |
Canadian Vascular Access Association
Spring2022
|
| Online Access: | View this record in EBSCOhost |